LYMPHOQUANT

WIPO WIPO 2018

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke LYMPHOQUANT wurde als Wortmarke am 27.02.2018 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 20. Oktober 2022

Markenform Wortmarke
Aktenzeichen 1404600
Länder Schweiz China Europäische Gemeinschaft Japan Südkorea
Basismarke US Nr. 87588377, 29. August 2017
Anmeldedatum 27. Februar 2018
Ablaufdatum 27. Februar 2028

Markeninhaber

10222 Barnes Canyon Road,
Building 1
US

Markenvertreter

Level 43, Bourke Place, 600 Bourke Street AU

Waren und Dienstleistungen

01 Reagents for scientific and research use, namely, buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of chemical and biological reagents for non-medical purposes; diagnostic reagents for scientific and research use; diagnostic assays for research, clinical research, and laboratory research use
05 Assays for the treatment or diagnosis of disease; medical diagnostic reagents, namely, buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; medical diagnostic kits comprised of buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; medical diagnostic reagent kits comprised of chemical and biological reagents for the treatment, monitoring and diagnosis of disease; medical diagnostic reagent kits comprised of medical reagents for clinical or medical use; medical diagnostic assays for the treatment and diagnosis of disease; medical diagnostic assays for testing of bodily fluids
42 DNA analysis services for scientific research purposes, namely, DNA sequencing, bioinformatics analysis, and interpretation of biological DNA data generated from reagents and assays
44 DNA screening for medical purposes, namely, DNA sequencing, bioinformatics analysis, and interpretation of biological DNA data generated from reagents and assays
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
01. Juni 2019 2019/23 Gaz KR RAW: Rule 18ter(2)(ii) GP following a provisional refusal
15. April 2019 2019/16 Gaz CH Ablehnung
28. Februar 2019 2019/9 Gaz JP Ablehnung
10. Dezember 2018 2019/1 Gaz CN Ablehnung
21. November 2018 2018/47 Gaz KR Ablehnung
06. November 2018 2018/45 Gaz EM Ablehnung
27. Februar 2018 2018/20 Gaz US Eintragung

ID: 141404600